Last reviewed · How we verify

NCT04131764

Diagnosis of ON With or Without MS or NMOSD

Terminated Last updated 14 November 2022
What this trial tests

trial testing Reflex (Brightlamp Inc., Purdue University) in Multiple Sclerosis in 112 participants. Terminated before completion.

Timeline
4 October 2019
Primary endpoint
6 September 2022
6 September 2022

Quick facts

Lead sponsorJagannadha R Avasarala
StatusTerminated
Study typeOBSERVATIONAL
Enrollment112
Start date4 October 2019
Primary completion6 September 2022
Estimated completion6 September 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Jagannadha R Avasarala

Who can join

Adults 18 to 90, any sex, with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder Attack. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is both a prospective and retrospective study of patients with a known diagnosis of optic neuritis (ON) only, multiple sclerosis (MS) with ON, or neuromyelitis spectrum disorder (NMOSD) with ON. There will be no requirement for blinding (patient or assessor) and data collected with the Reflex app will be compared against other data that track optic nerve functional status, such as optical coherence tomography (OCT), visual fields (VF), low-contrast sensitivity, MRI orbits/brain and visual evoked potentials (VEP). Patients who have any diagnosis of ON, with or without a diagnosis of MS or NMOSD and who have had testing using other modalities such as VEPs, VF, low-contrast sensitivity studies, OCT, and MRI of brain or orbits will be included as retrospective subjects in the study. In this cohort, RAPD assessments will be completed and compared to against the data that has accrued as noted.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Jagannadha R Avasarala trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04131764.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing